137 related articles for article (PubMed ID: 1409308)
1. Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study.
Auteri A; Pasqui AL; Bruni F; Saletti M; Di Renzo M; Bova G
Pharmacol Res; 1992 Sep; 26 Suppl 2():196-7. PubMed ID: 1409308
[No Abstract] [Full Text] [Related]
2. Ex vivo evaluation of Pidotimod effect on immune response.
Pugliese A; Marinelli L; Forno B; Pollono AM; Uslenghi C; Girardello R
Pharmacol Res; 1992 Sep; 26 Suppl 2():178-9. PubMed ID: 1409298
[No Abstract] [Full Text] [Related]
3. Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human neutrophils.
Capsoni F; Minonzio F; Ongari AM; Girardello R; Zanussi C
Pharmacol Res; 1992 Sep; 26 Suppl 2():172-3. PubMed ID: 1409296
[No Abstract] [Full Text] [Related]
4. [Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study].
Borghi MO; Minonzio F; Fain C; Carbonelli V; Barcellini W; Del Papa N; La Rosa L; Piona A; Gambini D; Meroni PL
Drugs Exp Clin Res; 1993; 19 Suppl():37-43. PubMed ID: 8625781
[No Abstract] [Full Text] [Related]
5. The in vitro effect of Pidotimod on some immune functions in cancer patients.
Di Renzo M; Pasqui AL; Bruni F; Saletti M; Bova G; Chiarion C; Girardello R; Ferrì P; Auteri A
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):37-51. PubMed ID: 9049658
[TBL] [Abstract][Full Text] [Related]
6. [Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress].
Pasqui AL; Bruni F; Di Renzo M; Saletti M; Bova G; Gotti G; Auteri A
Drugs Exp Clin Res; 1993; 19 Suppl():45-53. PubMed ID: 8625782
[No Abstract] [Full Text] [Related]
7. [Effect of pidotimod on phagocytosis and intracellular killing of Staphylococcus aureus by human circulating polymorphonuclear neutrophils and alveolar macrophages].
Oddera S; Silvestri M; Sacco O; Eftimiadi C; Rossi GA
Drugs Exp Clin Res; 1993; 19 Suppl():27-35. PubMed ID: 8625780
[No Abstract] [Full Text] [Related]
8. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
Barchielli M; Coppi G
Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
[No Abstract] [Full Text] [Related]
9. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
[No Abstract] [Full Text] [Related]
10. Pidotimod. A new biological response modifier. Introduction.
Maillard F
Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
[No Abstract] [Full Text] [Related]
11. Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Bernardini R
Pharmacol Toxicol; 1994; 74(4-5):262-6. PubMed ID: 8090697
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
[TBL] [Abstract][Full Text] [Related]
13. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
[TBL] [Abstract][Full Text] [Related]
14. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Migliorati G; D'Adamio L; Coppi G; Nicoletti I; Riccardi C
Immunopharmacol Immunotoxicol; 1992; 14(4):737-48. PubMed ID: 1294620
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
[No Abstract] [Full Text] [Related]
16. Immunomodulating activity of pidotimod.
Migliorati G; Nicoletti I; Riccardi C
Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
[TBL] [Abstract][Full Text] [Related]
17. Experimental immunological screening tests on pidotimod.
Coppi G; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
Magni A; Signorelli G; Bocchiola G
Arzneimittelforschung; 1994 Dec; 44(12A):1402-4. PubMed ID: 7857331
[TBL] [Abstract][Full Text] [Related]
19. [Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro].
Migliorati G; Nicoletti I; Delfino D; Maggioni A; Coppi G; Riccardi C
Drugs Exp Clin Res; 1993; 19 Suppl():1-7. PubMed ID: 8625777
[No Abstract] [Full Text] [Related]
20. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
